A classification tree approach for pituitary adenomas
It is difficult to evaluate the recurrence and progression potential of pituitary adenomas at presentation. The World Health Organization classification of endocrine tumors suggests that invasion of the surrounding structures, size at presentation, an elevated mitotic index, a Ki-67 labeling index h...
Saved in:
Published in | Human pathology Vol. 43; no. 10; pp. 1627 - 1637 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.10.2012
Elsevier Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | It is difficult to evaluate the recurrence and progression potential of pituitary adenomas at presentation. The World Health Organization classification of endocrine tumors suggests that invasion of the surrounding structures, size at presentation, an elevated mitotic index, a Ki-67 labeling index higher than 3%, and extensive p53 expression are indicators of aggressive behavior. Nevertheless, Ki-67 and p53 labeling index evaluation is subject to interobserver variability, and their cutoff values are controversial. In the present study, the prognostic value of Ki-67 and p53 protein labeling indices and their correlation with clinical and radiologic parameters were evaluated using digital image analysis in a series of 166 pituitary adenomas in patients having undergone a follow-up of at least 6 years to evaluate the impact on the recurrence and progression potential of pituitary adenomas. The data were analyzed using the receiver operating characteristic curve and classification and regression tree analysis. The results showed that, in the unstratified data set, the commonly used threshold of the Ki-67 index of 3% has a high specificity (89.5%) but a low sensitivity (53.8%). Unsatisfactory performance results were obtained by performing receiver operating characteristic curve analysis on the p53 labeling index. On the contrary, the classification and regression tree analysis–derived tree demonstrated that each pituitary adenoma subtype has specific prognostic factors. Specifically, the Ki-67 labeling index is a useful prognostic factor in nonfunctioning, adrenocorticotropin, and prolactin adenomas, but with different thresholds. In conclusion, our study emphasizes that the term pituitary adenomas includes different types of tumors, each one having specific prognostic factors. |
---|---|
AbstractList | It is difficult to evaluate the recurrence and progression potential of pituitary adenomas at presentation. The World Health Organization classification of endocrine tumors suggests that invasion of the surrounding structures, size at presentation, an elevated mitotic index, a Ki-67 labeling index higher than 3%, and extensive p53 expression are indicators of aggressive behavior. Nevertheless, Ki-67 and p53 labeling index evaluation is subject to interobserver variability, and their cutoff values are controversial. In the present study, the prognostic value of Ki-67 and p53 protein labeling indices and their correlation with clinical and radiologic parameters were evaluated using digital image analysis in a series of 166 pituitary adenomas in patients having undergone a follow-up of at least 6 years to evaluate the impact on the recurrence and progression potential of pituitary adenomas. The data were analyzed using the receiver operating characteristic curve and classification and regression tree analysis. The results showed that, in the unstratified data set, the commonly used threshold of the Ki-67 index of 3% has a high specificity (89.5%) but a low sensitivity (53.8%). Unsatisfactory performance results were obtained by performing receiver operating characteristic curve analysis on the p53 labeling index. On the contrary, the classification and regression tree analysis-derived tree demonstrated that each pituitary adenoma subtype has specific prognostic factors. Specifically, the Ki-67 labeling index is a useful prognostic factor in nonfunctioning, adrenocorticotropin, and prolactin adenomas, but with different thresholds. In conclusion, our study emphasizes that the term pituitary adenomas includes different types of tumors, each one having specific prognostic factors.It is difficult to evaluate the recurrence and progression potential of pituitary adenomas at presentation. The World Health Organization classification of endocrine tumors suggests that invasion of the surrounding structures, size at presentation, an elevated mitotic index, a Ki-67 labeling index higher than 3%, and extensive p53 expression are indicators of aggressive behavior. Nevertheless, Ki-67 and p53 labeling index evaluation is subject to interobserver variability, and their cutoff values are controversial. In the present study, the prognostic value of Ki-67 and p53 protein labeling indices and their correlation with clinical and radiologic parameters were evaluated using digital image analysis in a series of 166 pituitary adenomas in patients having undergone a follow-up of at least 6 years to evaluate the impact on the recurrence and progression potential of pituitary adenomas. The data were analyzed using the receiver operating characteristic curve and classification and regression tree analysis. The results showed that, in the unstratified data set, the commonly used threshold of the Ki-67 index of 3% has a high specificity (89.5%) but a low sensitivity (53.8%). Unsatisfactory performance results were obtained by performing receiver operating characteristic curve analysis on the p53 labeling index. On the contrary, the classification and regression tree analysis-derived tree demonstrated that each pituitary adenoma subtype has specific prognostic factors. Specifically, the Ki-67 labeling index is a useful prognostic factor in nonfunctioning, adrenocorticotropin, and prolactin adenomas, but with different thresholds. In conclusion, our study emphasizes that the term pituitary adenomas includes different types of tumors, each one having specific prognostic factors. It is difficult to evaluate the recurrence and progression potential of pituitary adenomas at presentation. The World Health Organization classification of endocrine tumors suggests that invasion of the surrounding structures, size at presentation, an elevated mitotic index, a Ki-67 labeling index higher than 3%, and extensive p53 expression are indicators of aggressive behavior. Nevertheless, Ki-67 and p53 labeling index evaluation is subject to interobserver variability, and their cutoff values are controversial. In the present study, the prognostic value of Ki-67 and p53 protein labeling indices and their correlation with clinical and radiologic parameters were evaluated using digital image analysis in a series of 166 pituitary adenomas in patients having undergone a follow-up of at least 6 years to evaluate the impact on the recurrence and progression potential of pituitary adenomas. The data were analyzed using the receiver operating characteristic curve and classification and regression tree analysis. The results showed that, in the unstratified data set, the commonly used threshold of the Ki-67 index of 3% has a high specificity (89.5%) but a low sensitivity (53.8%). Unsatisfactory performance results were obtained by performing receiver operating characteristic curve analysis on the p53 labeling index. On the contrary, the classification and regression tree analysis-derived tree demonstrated that each pituitary adenoma subtype has specific prognostic factors. Specifically, the Ki-67 labeling index is a useful prognostic factor in nonfunctioning, adrenocorticotropin, and prolactin adenomas, but with different thresholds. In conclusion, our study emphasizes that the term pituitary adenomas includes different types of tumors, each one having specific prognostic factors. Summary It is difficult to evaluate the recurrence and progression potential of pituitary adenomas at presentation. The World Health Organization classification of endocrine tumors suggests that invasion of the surrounding structures, size at presentation, an elevated mitotic index, a Ki-67 labeling index higher than 3%, and extensive p53 expression are indicators of aggressive behavior. Nevertheless, Ki-67 and p53 labeling index evaluation is subject to interobserver variability, and their cutoff values are controversial. In the present study, the prognostic value of Ki-67 and p53 protein labeling indices and their correlation with clinical and radiologic parameters were evaluated using digital image analysis in a series of 166 pituitary adenomas in patients having undergone a follow-up of at least 6 years to evaluate the impact on the recurrence and progression potential of pituitary adenomas. The data were analyzed using the receiver operating characteristic curve and classification and regression tree analysis. The results showed that, in the unstratified data set, the commonly used threshold of the Ki-67 index of 3% has a high specificity (89.5%) but a low sensitivity (53.8%). Unsatisfactory performance results were obtained by performing receiver operating characteristic curve analysis on the p53 labeling index. On the contrary, the classification and regression tree analysis–derived tree demonstrated that each pituitary adenoma subtype has specific prognostic factors. Specifically, the Ki-67 labeling index is a useful prognostic factor in nonfunctioning, adrenocorticotropin, and prolactin adenomas, but with different thresholds. In conclusion, our study emphasizes that the term pituitary adenomas includes different types of tumors, each one having specific prognostic factors. |
Author | Faustini-Fustini, Marco Farnedi, Anna Frank, Giorgio Menetti, Federico Agati, Raffaele Foschini, Maria P. Sisto, Andrea Agati, Patrizia Mazzatenta, Diego Righi, Alberto Marucci, Gianluca |
Author_xml | – sequence: 1 givenname: Alberto surname: Righi fullname: Righi, Alberto organization: Section of Anatomic Pathology, Department of Haematology and Oncology “L. e A. Seragnoli” University of Bologna, Bellaria Hospital, 40139 Bologna, Italy – sequence: 2 givenname: Patrizia surname: Agati fullname: Agati, Patrizia organization: Department of Statistics “P. Fortunati,” University of Bologna, 40126 Bologna, Italy – sequence: 3 givenname: Andrea surname: Sisto fullname: Sisto, Andrea organization: University of Eastern Piedmont, Polis-Public Policy and Choice, 15121 Alessandria, Italy – sequence: 4 givenname: Giorgio surname: Frank fullname: Frank, Giorgio organization: Center of Surgery for Pituitary Tumors, Bellaria Hospital, 10126 Bologna, Italy – sequence: 5 givenname: Marco surname: Faustini-Fustini fullname: Faustini-Fustini, Marco organization: Endocrine Unit, Department of Medicine, Bellaria Hospital, 10126 Bologna, Italy – sequence: 6 givenname: Raffaele surname: Agati fullname: Agati, Raffaele organization: Department of Neuroradiology, Bellaria Hospital, 40139 Bologna, Italy – sequence: 7 givenname: Diego surname: Mazzatenta fullname: Mazzatenta, Diego organization: Center of Surgery for Pituitary Tumors, Bellaria Hospital, 10126 Bologna, Italy – sequence: 8 givenname: Anna surname: Farnedi fullname: Farnedi, Anna organization: Section of Anatomic Pathology, Department of Haematology and Oncology “L. e A. Seragnoli” University of Bologna, Bellaria Hospital, 40139 Bologna, Italy – sequence: 9 givenname: Federico surname: Menetti fullname: Menetti, Federico organization: Department of Neuroradiology, Bellaria Hospital, 40139 Bologna, Italy – sequence: 10 givenname: Gianluca surname: Marucci fullname: Marucci, Gianluca organization: Section of Anatomic Pathology, Department of Haematology and Oncology “L. e A. Seragnoli” University of Bologna, Bellaria Hospital, 40139 Bologna, Italy – sequence: 11 givenname: Maria P. surname: Foschini fullname: Foschini, Maria P. email: mariapia.foschini@ausl.bo.it, mariapia.foschini@unibo.it organization: Section of Anatomic Pathology, Department of Haematology and Oncology “L. e A. Seragnoli” University of Bologna, Bellaria Hospital, 40139 Bologna, Italy |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26426067$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22446019$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkt2L1DAUxYOsuLOrf4JSEMGX1iRt0xZRWRa_YMEH9TncubllMvbLpBX2v_eWGV0YkPUpefidw8k5uRBnwziQEE-VzJRU5tU-2y39BPMu01KpTOlMyvyB2Kgy12mdN_pMbKQsTFqrqjoXFzHuJYNlUT4S51oXhZGq2YjyKsEOYvStR5j9OCRzIEpgmsIIuEvaMSSTnxc_Q7hNwNEw9hAfi4ctdJGeHM9L8f3D-2_Xn9KbLx8_X1_dpMgp5rSEEhS1EmSJBrGlYusKBQi50eSMNAaNy6tCOdNuXY2ydrCtG3KuRVbq_FK8PPhymp8Lxdn2PiJ1HQw0LtEqaRotq6rIGX1-gu7HJQycjqlaMiZzw9SzI7Vse3J2Cr7nh9k_hTDw4ghAROjaAAP6eMeZQnPuirnywGEYYwzU_kWUtOtAdm-PA9l1IKu05QSse32iQ652LX4O4Lt71e8OauLSf3kKNqKnAcn5QDhbN_p7Hd6eOGDnB96--0G3FO86s5EF9uv6hdYfpBTfGlOywZt_G_xHgN8Bfdf7 |
CODEN | HPCQA4 |
CitedBy_id | crossref_primary_10_1007_s11102_017_0855_1 crossref_primary_10_1155_2016_7964523 crossref_primary_10_1016_j_otc_2015_09_004 crossref_primary_10_1111_jne_13263 crossref_primary_10_1530_EJE_17_0796 crossref_primary_10_1007_s11102_024_01414_y crossref_primary_10_1530_EO_21_0026 crossref_primary_10_1007_s00701_014_1993_0 crossref_primary_10_1016_j_ecl_2014_10_001 crossref_primary_10_1530_EJE_15_0586 crossref_primary_10_1016_j_lpm_2021_104086 crossref_primary_10_5812_ijem_81983 crossref_primary_10_1016_j_humpath_2013_05_020 crossref_primary_10_1080_02688697_2024_2384748 crossref_primary_10_1007_s12022_016_9418_7 crossref_primary_10_3390_cancers12020514 crossref_primary_10_1016_j_ensci_2021_100317 crossref_primary_10_1530_EJE_17_0965 crossref_primary_10_1159_000375448 crossref_primary_10_1210_js_2019_00163 crossref_primary_10_1007_s00701_019_03879_4 crossref_primary_10_1016_j_clineuro_2016_03_021 crossref_primary_10_1530_EJE_15_1226 crossref_primary_10_1007_s12022_014_9322_y crossref_primary_10_1016_j_endoen_2014_02_011 crossref_primary_10_1007_s10014_022_00441_6 crossref_primary_10_1007_s11060_016_2365_9 crossref_primary_10_1016_j_jbi_2017_08_005 crossref_primary_10_3390_diagnostics14030274 crossref_primary_10_1093_neuros_nyx541 crossref_primary_10_1155_2013_983953 crossref_primary_10_1016_j_ando_2015_04_007 crossref_primary_10_1186_s40478_015_0229_8 crossref_primary_10_1530_EJE_13_1031 crossref_primary_10_1016_j_ando_2015_04_003 crossref_primary_10_1007_s40618_020_01275_9 crossref_primary_10_3390_cancers13236134 crossref_primary_10_1111_nan_12568 crossref_primary_10_1210_clinem_dgad673 crossref_primary_10_1007_s11060_013_1349_2 crossref_primary_10_1055_s_0041_1735874 crossref_primary_10_1097_PAI_0000000000000303 crossref_primary_10_1111_cen_14197 crossref_primary_10_56782_pps_114 crossref_primary_10_1007_s00401_013_1084_y crossref_primary_10_1016_j_wneu_2018_05_077 crossref_primary_10_1007_s11102_013_0500_6 crossref_primary_10_1210_jc_2017_00773 crossref_primary_10_1007_s12020_016_0940_7 crossref_primary_10_1016_j_endonu_2013_04_009 crossref_primary_10_2217_ije_2015_0011 |
Cites_doi | 10.1677/ERC-07-0062 10.1590/S0100-879X2004000200011 10.1227/01.NEU.0000223437.51435.6E 10.1038/modpathol.2010.58 10.1007/s00401-005-1093-6 10.1111/j.1365-2559.2010.03495.x 10.1210/jc.2009-0471 10.1007/s00401-005-1105-6 10.1080/01621459.1958.10501452 10.1227/01.NEU.0000349930.66434.82 10.1017/S0317167100002614 10.1677/erc.0.0090103 10.1210/jc.2008-0126 10.1111/j.1365-2265.2006.02630.x 10.3346/jkms.2005.20.3.489 10.1227/00006123-198912000-00012 10.1054/bjoc.1999.1074 10.1177/002215540104900916 10.1080/01616412.1985.11739714 10.3171/jns.1993.78.5.0753 10.1097/00006123-200012000-00009 10.1007/BF03346512 10.1023/A:1012940929072 10.5858/2008-132-1231-PPPWDT 10.1016/j.humpath.2007.10.004 10.3171/jns.2002.96.2.0195 10.1530/eje.1.02298 10.1530/EJE-07-0099 10.1136/jcp.52.2.107 |
ContentType | Journal Article |
Copyright | 2012 Elsevier Inc. Elsevier Inc. 2015 INIST-CNRS Copyright © 2012 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2012 Elsevier Inc. – notice: Elsevier Inc. – notice: 2015 INIST-CNRS – notice: Copyright © 2012 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM K9. 7X8 |
DOI | 10.1016/j.humpath.2011.12.003 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1532-8392 |
EndPage | 1637 |
ExternalDocumentID | 2773222641 22446019 26426067 10_1016_j_humpath_2011_12_003 S0046817711004965 1_s2_0_S0046817711004965 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1CY 1P~ 1RT 1~. 1~5 3O- 4.4 457 4CK 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQOH AAQQT AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABLJU ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV BPHCQ BVXVI CAG COF DU5 EBS EFJIC EFKBS EJD EMOBN EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDY HMK HMO HVGLF HZ~ IH2 IHE J1W J5H K-O KOM L7B M29 M41 MO0 N9A O-L O9- OAUVE OG0 OS0 OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 R2- ROL RPZ SAE SDF SDG SDP SEL SES SEW SJN SPCBC SSH SSZ SV3 T5K UGJ UHS UNMZH UV1 WUQ X7M Z5R ZGI ~G- 3V. 7X7 8FI AACTN AFCTW AFKRA AFKWA AJOXV AMFUW AZQEC BENPR FYUFA GUQSH M1P M2O RIG AAYXX AGRNS CITATION IQODW CGR CUY CVF ECM EIF NPM K9. 7X8 |
ID | FETCH-LOGICAL-c532t-5a5a1ef0a05c6ccfe4bd41aca362ed6066c6d3741d6fbd8c08dab89eddfc5a123 |
IEDL.DBID | .~1 |
ISSN | 0046-8177 1532-8392 |
IngestDate | Fri Jul 11 06:03:14 EDT 2025 Sun Jul 13 03:57:30 EDT 2025 Thu Apr 03 07:05:26 EDT 2025 Mon Jul 21 09:14:58 EDT 2025 Thu Apr 24 23:11:26 EDT 2025 Tue Jul 01 02:24:16 EDT 2025 Sun Apr 06 06:53:56 EDT 2025 Sun Feb 23 10:19:16 EST 2025 Tue Aug 26 16:33:13 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | Ki-67 Prognosis Pituitary adenoma p53 Endocrinopathy Biological marker Anatomic pathology TP53 Gene Classification Pituitary diseases Ki67 antigen Tree Tumor suppressor gene |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright © 2012 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c532t-5a5a1ef0a05c6ccfe4bd41aca362ed6066c6d3741d6fbd8c08dab89eddfc5a123 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 content type line 14 ObjectType-Feature-3 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
PMID | 22446019 |
PQID | 1080920036 |
PQPubID | 105547 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_1069207743 proquest_journals_1080920036 pubmed_primary_22446019 pascalfrancis_primary_26426067 crossref_primary_10_1016_j_humpath_2011_12_003 crossref_citationtrail_10_1016_j_humpath_2011_12_003 elsevier_sciencedirect_doi_10_1016_j_humpath_2011_12_003 elsevier_clinicalkeyesjournals_1_s2_0_S0046817711004965 elsevier_clinicalkey_doi_10_1016_j_humpath_2011_12_003 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-10-01 |
PublicationDateYYYYMMDD | 2012-10-01 |
PublicationDate_xml | – month: 10 year: 2012 text: 2012-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York, NY |
PublicationPlace_xml | – name: New York, NY – name: United States – name: Philadelphia |
PublicationTitle | Human pathology |
PublicationTitleAlternate | Hum Pathol |
PublicationYear | 2012 |
Publisher | Elsevier Inc Elsevier Elsevier Limited |
Publisher_xml | – name: Elsevier Inc – name: Elsevier – name: Elsevier Limited |
References | Gejman, Swearingen, Hedley-Whyte (bb0060) 2008; 39 Nakabayashi, Sunada, Hara (bb0050) 2001; 49 Noh, Jeong, Lee, Kim, Kim, Lee (bb0075) 2009; 94 Losa, Franzin, Mangili (bb0080) 2000; 47 Scheithauer, Gaffey, Lloyd (bb0030) 2006; 59 Ogawa, Ikeda, Tominaga (bb0085) 2009; 32 Wierinckx, Auger, Devauchelle (bb0095) 2007; 14 Fusco, Zatelli, Bianchi (bb0065) 2008; 93 Wang, Qian, Rahman (bb0100) 2010; 56 Lloyd (bb0120) 2001; 54 Breiman, Friedman, Olshen, Stone (bb0145) 1984 Jaffrain-Rea, Di Stefano, Minniti (bb0045) 2002; 9 Dubois, Guyétant, Menei (bb0015) 2007; 157 Hsu, Hakim, Biller (bb0135) 1993; 78 Scarpa, Mantovani, Capelli (bb0125) 2010; 23 Pizarro, Oliveira, Coutinho, Ferreira (bb0025) 2004; 37 Knosp, Kitz, Perneczky (bb0130) 1989; 25 Kleinschmidt-DeMasters (bb0155) 2006; 111 Paek, Kim, Song (bb0055) 2005; 20 Auer, Clarici (bb0110) 1985; 7 Mastronardi, Guiducci, Spera, Puzzilli, Liberati, Maira (bb0090) 1999; 52 Asa (bb0115) 2008; 132 Lloyd, Kovacs, Young (bb0010) 2004 Filippella, Galland, Kujas (bb0040) 2006; 65 Al-Shraim, Asa (bb0150) 2006; 111 Meij, Lopes, Ellegala, Alden, Laws (bb0070) 2002; 96 Salehi, Agur, Scheithauer, Kovacs, Lloyd, Cusimano (bb0005) 2009; 65 Turner, Nagy, Gatter, Esiri, Wass, Harris (bb0035) 2000; 82 Hentschel, McCutcheon, Moore, Durity (bb0020) 2003; 30 Ferrante, Ferraroni, Castrignanò (bb0105) 2006; 155 Kaplan, Meier (bb0140) 1958; 53 Lloyd (10.1016/j.humpath.2011.12.003_bb0120) 2001; 54 Hsu (10.1016/j.humpath.2011.12.003_bb0135) 1993; 78 Mastronardi (10.1016/j.humpath.2011.12.003_bb0090) 1999; 52 Noh (10.1016/j.humpath.2011.12.003_bb0075) 2009; 94 Salehi (10.1016/j.humpath.2011.12.003_bb0005) 2009; 65 Losa (10.1016/j.humpath.2011.12.003_bb0080) 2000; 47 Scarpa (10.1016/j.humpath.2011.12.003_bb0125) 2010; 23 Al-Shraim (10.1016/j.humpath.2011.12.003_bb0150) 2006; 111 Kleinschmidt-DeMasters (10.1016/j.humpath.2011.12.003_bb0155) 2006; 111 Filippella (10.1016/j.humpath.2011.12.003_bb0040) 2006; 65 Lloyd (10.1016/j.humpath.2011.12.003_bb0010) 2004 Hentschel (10.1016/j.humpath.2011.12.003_bb0020) 2003; 30 Gejman (10.1016/j.humpath.2011.12.003_bb0060) 2008; 39 Pizarro (10.1016/j.humpath.2011.12.003_bb0025) 2004; 37 Auer (10.1016/j.humpath.2011.12.003_bb0110) 1985; 7 Jaffrain-Rea (10.1016/j.humpath.2011.12.003_bb0045) 2002; 9 Dubois (10.1016/j.humpath.2011.12.003_bb0015) 2007; 157 Ferrante (10.1016/j.humpath.2011.12.003_bb0105) 2006; 155 Turner (10.1016/j.humpath.2011.12.003_bb0035) 2000; 82 Nakabayashi (10.1016/j.humpath.2011.12.003_bb0050) 2001; 49 Asa (10.1016/j.humpath.2011.12.003_bb0115) 2008; 132 Ogawa (10.1016/j.humpath.2011.12.003_bb0085) 2009; 32 Breiman (10.1016/j.humpath.2011.12.003_bb0145) 1984 Scheithauer (10.1016/j.humpath.2011.12.003_bb0030) 2006; 59 Fusco (10.1016/j.humpath.2011.12.003_bb0065) 2008; 93 Wang (10.1016/j.humpath.2011.12.003_bb0100) 2010; 56 Wierinckx (10.1016/j.humpath.2011.12.003_bb0095) 2007; 14 Kaplan (10.1016/j.humpath.2011.12.003_bb0140) 1958; 53 Knosp (10.1016/j.humpath.2011.12.003_bb0130) 1989; 25 Paek (10.1016/j.humpath.2011.12.003_bb0055) 2005; 20 Meij (10.1016/j.humpath.2011.12.003_bb0070) 2002; 96 |
References_xml | – volume: 94 start-page: 4406 year: 2009 end-page: 4413 ident: bb0075 article-title: Predicting recurrence of nonfunctioning pituitary adenomas publication-title: J Clin Endocrinol Metab – volume: 59 start-page: 341 year: 2006 end-page: 353 ident: bb0030 article-title: Pathobiology of pituitary adenomas and carcinomas publication-title: Neurosurgery – volume: 30 start-page: 215 year: 2003 end-page: 219 ident: bb0020 article-title: P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas publication-title: Can J Neurol Sci – volume: 82 start-page: 1441 year: 2000 end-page: 1445 ident: bb0035 article-title: Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumor behaviour publication-title: Br J Cancer – volume: 39 start-page: 758 year: 2008 end-page: 766 ident: bb0060 article-title: Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas publication-title: H – volume: 93 start-page: 2746 year: 2008 end-page: 2750 ident: bb0065 article-title: Prognostic significance of the Ki-67 labeling index in growth hormone–secreting pituitary adenomas publication-title: J Clin Endocrinol Metab – volume: 65 start-page: 536 year: 2006 end-page: 543 ident: bb0040 article-title: Pituitary tumor transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study publication-title: Clin Endocrinol – volume: 32 start-page: 581 year: 2009 end-page: 584 ident: bb0085 article-title: Clinicopathological study of prognostic factors in patients with pituitary adenomas and Ki-67 labeling index of more than 3% publication-title: Endocrinol Invest – volume: 155 start-page: 823 year: 2006 end-page: 829 ident: bb0105 article-title: Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors publication-title: Eur J Endocrinol – volume: 25 start-page: 927 year: 1989 end-page: 930 ident: bb0130 article-title: Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67 publication-title: Neurosurgery – year: 1984 ident: bb0145 article-title: Classification and regression trees – volume: 157 start-page: 141 year: 2007 end-page: 147 ident: bb0015 article-title: Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery publication-title: Eur J Endocrinol – start-page: 10 year: 2004 end-page: 47 ident: bb0010 article-title: Tumors of the pituitary publication-title: World Health Organization classification of tumors: pathology and genetics: tumors of endocrine organs – volume: 78 start-page: 753 year: 1993 end-page: 761 ident: bb0135 article-title: Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence publication-title: J Neurosurg – volume: 65 start-page: 429 year: 2009 end-page: 437 ident: bb0005 article-title: Ki-67 in pituitary neoplasms: a review—part I publication-title: Neurosurgery – volume: 14 start-page: 887 year: 2007 end-page: 900 ident: bb0095 article-title: A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors publication-title: Endocr Relat Cancer – volume: 132 start-page: 1231 year: 2008 end-page: 1240 ident: bb0115 article-title: Practical pituitary pathology: what does the pathologist need to know? publication-title: Arch Pathol Lab Med – volume: 56 start-page: 501 year: 2010 end-page: 509 ident: bb0100 article-title: Increased expression of HMGA1 correlates with tumor invasiveness and proliferation in human pituitary adenomas publication-title: Histopathology – volume: 47 start-page: 1313 year: 2000 end-page: 1318 ident: bb0080 article-title: Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results publication-title: Neurosurgery – volume: 20 start-page: 489 year: 2005 end-page: 494 ident: bb0055 article-title: Clinical significance of Ki-67 labeling index in pituitary macroadenoma publication-title: J Korean Med Sci – volume: 111 start-page: 1 year: 2006 end-page: 7 ident: bb0150 article-title: The 2004 World Health Organization classification of pituitary tumors: what is new? publication-title: Acta Neuropathol – volume: 23 start-page: 824 year: 2010 end-page: 833 ident: bb0125 article-title: Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients publication-title: Mod Pathol – volume: 9 start-page: 103 year: 2002 end-page: 113 ident: bb0045 article-title: A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumors: secreting versus non-secreting adenomas publication-title: Endocr Relat Cancer – volume: 37 start-page: 235 year: 2004 end-page: 243 ident: bb0025 article-title: Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody publication-title: Braz J Med Biol Res – volume: 52 start-page: 107 year: 1999 end-page: 111 ident: bb0090 article-title: Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody publication-title: J Clin Pathol – volume: 49 start-page: 1193 year: 2001 end-page: 1194 ident: bb0050 article-title: Immunohistochemical analyses of cell cycle–related proteins, apoptosis, and proliferation in pituitary adenomas publication-title: J Histochem Cytochem – volume: 54 start-page: 111 year: 2001 end-page: 119 ident: bb0120 article-title: Molecular pathology of pituitary adenomas publication-title: J Neurooncol – volume: 111 start-page: 84 year: 2006 end-page: 85 ident: bb0155 article-title: Subtyping does matter in pituitary adenomas publication-title: Acta Neuropathol – volume: 96 start-page: 195 year: 2002 end-page: 208 ident: bb0070 article-title: The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery publication-title: J Neurosurg – volume: 7 start-page: 153 year: 1985 end-page: 160 ident: bb0110 article-title: The first 100 transsphenoidally operated pituitary adenomas in a non-specialised centre: surgical results and tumor-recurrence publication-title: Neurol Res – volume: 53 start-page: 457 year: 1958 end-page: 481 ident: bb0140 article-title: Nonparametric estimation from incomplete observations publication-title: J Am Stat Assoc – volume: 14 start-page: 887 year: 2007 ident: 10.1016/j.humpath.2011.12.003_bb0095 article-title: A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors publication-title: Endocr Relat Cancer doi: 10.1677/ERC-07-0062 – start-page: 10 year: 2004 ident: 10.1016/j.humpath.2011.12.003_bb0010 article-title: Tumors of the pituitary – volume: 37 start-page: 235 year: 2004 ident: 10.1016/j.humpath.2011.12.003_bb0025 article-title: Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody publication-title: Braz J Med Biol Res doi: 10.1590/S0100-879X2004000200011 – volume: 59 start-page: 341 year: 2006 ident: 10.1016/j.humpath.2011.12.003_bb0030 article-title: Pathobiology of pituitary adenomas and carcinomas publication-title: Neurosurgery doi: 10.1227/01.NEU.0000223437.51435.6E – volume: 23 start-page: 824 year: 2010 ident: 10.1016/j.humpath.2011.12.003_bb0125 article-title: Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients publication-title: Mod Pathol doi: 10.1038/modpathol.2010.58 – volume: 111 start-page: 1 year: 2006 ident: 10.1016/j.humpath.2011.12.003_bb0150 article-title: The 2004 World Health Organization classification of pituitary tumors: what is new? publication-title: Acta Neuropathol doi: 10.1007/s00401-005-1093-6 – volume: 56 start-page: 501 year: 2010 ident: 10.1016/j.humpath.2011.12.003_bb0100 article-title: Increased expression of HMGA1 correlates with tumor invasiveness and proliferation in human pituitary adenomas publication-title: Histopathology doi: 10.1111/j.1365-2559.2010.03495.x – volume: 94 start-page: 4406 year: 2009 ident: 10.1016/j.humpath.2011.12.003_bb0075 article-title: Predicting recurrence of nonfunctioning pituitary adenomas publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2009-0471 – volume: 111 start-page: 84 year: 2006 ident: 10.1016/j.humpath.2011.12.003_bb0155 article-title: Subtyping does matter in pituitary adenomas publication-title: Acta Neuropathol doi: 10.1007/s00401-005-1105-6 – volume: 53 start-page: 457 year: 1958 ident: 10.1016/j.humpath.2011.12.003_bb0140 article-title: Nonparametric estimation from incomplete observations publication-title: J Am Stat Assoc doi: 10.1080/01621459.1958.10501452 – volume: 65 start-page: 429 year: 2009 ident: 10.1016/j.humpath.2011.12.003_bb0005 article-title: Ki-67 in pituitary neoplasms: a review—part I publication-title: Neurosurgery doi: 10.1227/01.NEU.0000349930.66434.82 – volume: 30 start-page: 215 year: 2003 ident: 10.1016/j.humpath.2011.12.003_bb0020 article-title: P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas publication-title: Can J Neurol Sci doi: 10.1017/S0317167100002614 – volume: 9 start-page: 103 year: 2002 ident: 10.1016/j.humpath.2011.12.003_bb0045 article-title: A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumors: secreting versus non-secreting adenomas publication-title: Endocr Relat Cancer doi: 10.1677/erc.0.0090103 – volume: 93 start-page: 2746 year: 2008 ident: 10.1016/j.humpath.2011.12.003_bb0065 article-title: Prognostic significance of the Ki-67 labeling index in growth hormone–secreting pituitary adenomas publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2008-0126 – volume: 65 start-page: 536 year: 2006 ident: 10.1016/j.humpath.2011.12.003_bb0040 article-title: Pituitary tumor transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study publication-title: Clin Endocrinol doi: 10.1111/j.1365-2265.2006.02630.x – volume: 20 start-page: 489 year: 2005 ident: 10.1016/j.humpath.2011.12.003_bb0055 article-title: Clinical significance of Ki-67 labeling index in pituitary macroadenoma publication-title: J Korean Med Sci doi: 10.3346/jkms.2005.20.3.489 – volume: 25 start-page: 927 year: 1989 ident: 10.1016/j.humpath.2011.12.003_bb0130 article-title: Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67 publication-title: Neurosurgery doi: 10.1227/00006123-198912000-00012 – volume: 82 start-page: 1441 year: 2000 ident: 10.1016/j.humpath.2011.12.003_bb0035 article-title: Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumor behaviour publication-title: Br J Cancer doi: 10.1054/bjoc.1999.1074 – volume: 49 start-page: 1193 year: 2001 ident: 10.1016/j.humpath.2011.12.003_bb0050 article-title: Immunohistochemical analyses of cell cycle–related proteins, apoptosis, and proliferation in pituitary adenomas publication-title: J Histochem Cytochem doi: 10.1177/002215540104900916 – volume: 7 start-page: 153 year: 1985 ident: 10.1016/j.humpath.2011.12.003_bb0110 article-title: The first 100 transsphenoidally operated pituitary adenomas in a non-specialised centre: surgical results and tumor-recurrence publication-title: Neurol Res doi: 10.1080/01616412.1985.11739714 – volume: 78 start-page: 753 year: 1993 ident: 10.1016/j.humpath.2011.12.003_bb0135 article-title: Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence publication-title: J Neurosurg doi: 10.3171/jns.1993.78.5.0753 – volume: 47 start-page: 1313 year: 2000 ident: 10.1016/j.humpath.2011.12.003_bb0080 article-title: Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results publication-title: Neurosurgery doi: 10.1097/00006123-200012000-00009 – volume: 32 start-page: 581 year: 2009 ident: 10.1016/j.humpath.2011.12.003_bb0085 article-title: Clinicopathological study of prognostic factors in patients with pituitary adenomas and Ki-67 labeling index of more than 3% publication-title: Endocrinol Invest doi: 10.1007/BF03346512 – volume: 54 start-page: 111 year: 2001 ident: 10.1016/j.humpath.2011.12.003_bb0120 article-title: Molecular pathology of pituitary adenomas publication-title: J Neurooncol doi: 10.1023/A:1012940929072 – volume: 132 start-page: 1231 year: 2008 ident: 10.1016/j.humpath.2011.12.003_bb0115 article-title: Practical pituitary pathology: what does the pathologist need to know? publication-title: Arch Pathol Lab Med doi: 10.5858/2008-132-1231-PPPWDT – volume: 39 start-page: 758 year: 2008 ident: 10.1016/j.humpath.2011.12.003_bb0060 article-title: Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas publication-title: Hum Pathol doi: 10.1016/j.humpath.2007.10.004 – volume: 96 start-page: 195 year: 2002 ident: 10.1016/j.humpath.2011.12.003_bb0070 article-title: The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery publication-title: J Neurosurg doi: 10.3171/jns.2002.96.2.0195 – volume: 155 start-page: 823 year: 2006 ident: 10.1016/j.humpath.2011.12.003_bb0105 article-title: Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors publication-title: Eur J Endocrinol doi: 10.1530/eje.1.02298 – volume: 157 start-page: 141 year: 2007 ident: 10.1016/j.humpath.2011.12.003_bb0015 article-title: Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery publication-title: Eur J Endocrinol doi: 10.1530/EJE-07-0099 – year: 1984 ident: 10.1016/j.humpath.2011.12.003_bb0145 – volume: 52 start-page: 107 year: 1999 ident: 10.1016/j.humpath.2011.12.003_bb0090 article-title: Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody publication-title: J Clin Pathol doi: 10.1136/jcp.52.2.107 |
SSID | ssj0011545 |
Score | 2.284551 |
Snippet | It is difficult to evaluate the recurrence and progression potential of pituitary adenomas at presentation. The World Health Organization classification of... Summary It is difficult to evaluate the recurrence and progression potential of pituitary adenomas at presentation. The World Health Organization... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1627 |
SubjectTerms | Abbreviations Accuracy Adult Area Under Curve Biological and medical sciences Biomarkers, Tumor - analysis Biomarkers, Tumor - metabolism Classification Confidence intervals Disease Progression Endocrinopathies Female Humans Hypothalamus. Hypophysis. Epiphysis (diseases) Investigative techniques, diagnostic techniques (general aspects) Ki-67 Ki-67 Antigen - analysis Ki-67 Antigen - metabolism Male Medical imaging Medical sciences Middle Aged Non tumoral diseases. Target tissue resistance. Benign neoplasms p53 Pathology Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques Pituitary adenoma Pituitary Neoplasms - classification Pituitary Neoplasms - metabolism Pituitary Neoplasms - pathology Prognosis ROC Curve Sensitivity and Specificity Studies Tumor Suppressor Protein p53 - analysis Tumor Suppressor Protein p53 - metabolism Tumors |
Title | A classification tree approach for pituitary adenomas |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0046817711004965 https://www.clinicalkey.es/playcontent/1-s2.0-S0046817711004965 https://dx.doi.org/10.1016/j.humpath.2011.12.003 https://www.ncbi.nlm.nih.gov/pubmed/22446019 https://www.proquest.com/docview/1080920036 https://www.proquest.com/docview/1069207743 |
Volume | 43 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwED9EQQQRv60fo4Kv3dY2TdPHIcp0zAdR9C2kaYoTmcN1D774t3u3ph1jysSn0S3XpNfL3e-W-wC4wC2DRi9G3wSNj8dS5XtJINBxTX0hEoUGO6Tc4f4d7z6y2-foeQUuq1wYCqu0ur_U6VNtbb9pWW62RoMB5fgyLnych4qeJZwSzRmLScqbX3WYB1WbKbsYMO7R6FkWT-u1-YIsQ6BVVvKkfwWr3lmL9mlzpMbItbxsd_E7Hp3apett2LKA0u2Ua96BFTPchfW-PTLfg6jjakLIFBI0fQsunUO7VS1xF0GrOxoUk0GhPj5dhWqIIob24fH66uGy69leCZ6OwqDwIhUp3-Rt1Y401zo3LM2Yr7RCA2Uy8lI0z0KEDxnP00zotshUKhKTZblGyiA8gNXh-9AcgesjIgtSzUyYCpYrJgyqTc3aJowDzQPmAKs4JLUtJE79LN5kFTH2Ki1jJTFW-gFVIHWgWZONykoaywh4xX5ZpYmiYpOo65cRxj8RmrHdnmPpyzGOlAsi5ICoKeek8C-TNuYkpH5GRJzoM_LYgdNKZORsIQjYE4oP5A6c1z_jDqdjGzU07xMaw3EIwnSc47AUtdnNEZ2hS50c_3_hJ7CBV0EZoHgKq8XHxJwh0CrSxnQnNWCtc9Pr3tFn7_6p9w1JhCfo |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwED90AxVE_LZ-zAq-1q1tmqWPQ5T5sT0p-BbSNMUN2cbWPfjfe7emHaKi-NrmmvR6uftd7yMAl7hl0Oi10TdB4-OxRPleHAh0XBNfiFihwQ6pdrjX591ndv8SvazAdVkLQ2mVVvcXOn2hre2VpuVmczIYUI0v48LHeajpWcyjVahTd6qoBvXO3UO3XwUTCCUUgWbuEcGykKc5vHpFriHWKpp50o_B8visryZqc6JmyLisOPHiZ0i6ME2327BlMaXbKZa9AytmtAtrPRs134Oo42oCyZQVtPgQLoWi3bKduIu41Z0M8vkgV9N3V6EmoqShfXi-vXm67nr2uARPR2GQe5GKlG-ylmpFmmudGZakzFdaoY0yKTkqmqchIoiUZ0kqdEukKhGxSdNMI2UQHkBtNB6ZI3B9BGVBopkJE8EyxYRBzalZy4TtQPOAOcBKDklte4nTkRZvskwaG0rLWEmMlX5ATUgduKrIJkUzjd8IeMl-WVaKom6TqO5_I2x_R2hmdofOpC9nOFJ-kSIHREX5SRD_Mmnjk4RU74igE91G3nbgtBQZuVwIYvaYUgS5AxfVbdzkFLlRIzOe0xiOQxCp4xyHhagtH44ADb3q-Pj_Cz-H9e5T71E-3vUfTmAD7wRFvuIp1PLp3Jwh7sqTht1XHxHAKPY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+classification+tree+approach+for+pituitary+adenomas&rft.jtitle=Human+pathology&rft.au=Righi%2C+Alberto%2C+MD&rft.au=Agati%2C+Patrizia%2C+BSI%2C+PhD&rft.au=Sisto%2C+Andrea%2C+BSI&rft.au=Frank%2C+Giorgio%2C+MD&rft.date=2012-10-01&rft.issn=0046-8177&rft.volume=43&rft.issue=10&rft.spage=1627&rft.epage=1637&rft_id=info:doi/10.1016%2Fj.humpath.2011.12.003&rft.externalDBID=ECK1-s2.0-S0046817711004965&rft.externalDocID=1_s2_0_S0046817711004965 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00468177%2FS0046817712X00091%2Fcov150h.gif |